Antiseizure medications for post‐stroke epilepsy: A real‐world prospective cohort study
Brain and Behavior2021Vol. 11(9), pp. e2330–e2330
Citations Over TimeTop 10% of 2021 papers
Tomotaka Tanaka, Kazuki Fukuma, Soichiro Abe, Soichiro Matsubara, Rie Motoyama, Masahiro Mizobuchi, Hajime Yoshimura, Takayuki Matsuki, Yasuhiro Manabe, Junichiro Suzuki, Shuhei Ikeda, Naruhiko Kamogawa, Hiroyuki Ishiyama, Katsuya Kobayashi, Akihiro Shimotake, Kunihiro Nishimura, Daisuke Onozuka, Masatoshi Koga, Ḱazunori Toyoda, Shigeo Murayama, Riki Matsumoto, Ryōsuke Takahashi, Akio Ikeda, Masafumi Ihara, for the PROPOSE Study Investigators
Abstract
Newer-generation ASM possess advantages over older-generation ASM for secondary prophylaxis of post-stroke seizures in clinical practice.
Related Papers
- → Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers(2016)53 cited
- → Drug tolerability: How much ambiguity can be tolerated? A systematic review of the assessment of tolerability in clinical studies(2021)45 cited
- → Safety and Tolerability of Gabapentin as Adjunctive Therapy in a Large, Multicenter Study(1999)81 cited
- → Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study(2022)4 cited
- Tolerability of topical antimicrobials in treatment of acne vulgaris.(2014)